Predicting multi-level drug response with gene expression profile in multiple myeloma using hierarchical ordinal regression

Multiple myeloma (MM), like other cancers, is caused by the accumulation of genetic abnormalities. Heterogeneity exists in the patients’ response to treatments, for example, bortezomib.